Sign in

CIK 0001665988 · Accelerated filer<br>Emerging growth company

Bioventus Inc.

Sign in to watch
Ticker
BVS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
810980861
Phone
(919) 474-6700
Business address
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
  1. 4 Option exercise SVP & General Counsel acquired 9,925 shares (option exercise)
  2. 4 Option exercise SVP & Chief Compliance Officer acquired 4,300 shares (option exercise)
  3. 4 Planned sale SVP & CFO sold 5,479 shares at $9.79 ($53,639)
  4. 144 Insider Sale of Securities
  5. 4 Option exercise SVP & CFO acquired 18,625 shares (option exercise)
  6. 4 Planned sale SVP & Chief Compliance Officer sold 1,018 shares at $9.75 ($9,926)
  7. 4 Planned sale SVP & General Counsel sold 2,615 shares at $9.75 ($25,496)
  8. 4 Option exercise SVP & Chief Compliance Officer acquired 3,456 shares (option exercise)
  9. 4 Option exercise SVP & General Counsel acquired 8,886 shares (option exercise)
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. 4 Planned sale SVP & CFO sold 6,498 shares at $10.19 ($66,215)
  14. 4 Planned sale SVP & General Counsel sold 4,380 shares at $10.19 ($44,632)
  15. 4 Planned sale SVP & Chief Compliance Officer sold 1,537 shares at $10.19 ($15,662)
  16. 4 Option exercise SVP & CFO acquired 20,153 shares (option exercise)
  17. 4 Option exercise SVP & General Counsel acquired 12,980 shares (option exercise)
  18. 4 Option exercise SVP & Chief Compliance Officer acquired 4,375 shares (option exercise)
  19. 4 Planned sale President and CEO sold 28,786 shares at $9.10 ($261,953)
  20. 144 Insider Sale of Securities

Page 5 of 24 · 463 filings